2002
DOI: 10.1177/153537020222700409
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Modified Diabetic Splenocytes on Mice Injected with Multiple Low-Dose Streptozotocin

Abstract: This work reports the effects of a previous injection of mitomycin-modified splenocytes from multiple-low dose streptozotocin-treated mice (mld-sz) on autoimmune diabetes produced by mld-sz. Our work shows that a previous inoculation of modified mononuclear splenocytes from mld-sz mice prevents alterations in glycemia, in insulin secretion (IS) pattern from isolated perifused islets, and in mass of pancreatic islets. Immunohistochemistry showed an alteration in the number of beta, but not of alpha or delta cel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 33 publications
0
5
0
Order By: Relevance
“…23 The immunologic component in the mld-SZ diabetic model is highlighted by the absence of diabetes development in T-cell-deficient mice and by the protective effects of immunosuppressive or anti-inflammatory compounds 4,9,22,24,25 or vaccination with modified autoreactive lymphocytes. 5,6 It has been shown that mld-SZ administration depresses some constituents of the immune system, such as CD4 + T cells and some T-cell reactions, whereas macrophage activity and nonspecific cytotoxicity and production of interferon-g are activated. 26,27 Immune responses regulated by local cytokines may contribute to the diabetic state induced by mld-SZ because reduction and up-regulation of T H 2-type cytokines were, respectively, associated with susceptibility and resistance to mld-STZ-induced diabetes.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…23 The immunologic component in the mld-SZ diabetic model is highlighted by the absence of diabetes development in T-cell-deficient mice and by the protective effects of immunosuppressive or anti-inflammatory compounds 4,9,22,24,25 or vaccination with modified autoreactive lymphocytes. 5,6 It has been shown that mld-SZ administration depresses some constituents of the immune system, such as CD4 + T cells and some T-cell reactions, whereas macrophage activity and nonspecific cytotoxicity and production of interferon-g are activated. 26,27 Immune responses regulated by local cytokines may contribute to the diabetic state induced by mld-SZ because reduction and up-regulation of T H 2-type cytokines were, respectively, associated with susceptibility and resistance to mld-STZ-induced diabetes.…”
Section: Discussionmentioning
confidence: 99%
“…In these mice, a diminished insulin secretion is present 15 days after the transfer procedure, and a preferential trapping of transferred lymphocytes in islets of recipient mice was observed. 5,6,8,9 The aim of this study was to investigate the ability of mononuclear spleen cells (MSs) from treated mice to impair insulin secretion in normal recipient mice or in cultured dispersed rat islet cells at different days after mld-SZ administration. With this purpose, we studied insulin secretion patterns in mice transferred with MSs isolated from mld-SZ donors and the capacity of MSs from mld-SZ mice to exert an in vitro antib-cell immune aggression.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Multiple slides (3e4) randomly selected from each pancreas were evaluated for mononuclear cell infiltration. Severity of infiltration was classified into five categories as previously reported [19]: no infiltration, polar islet infiltration, peri-islet (surrounding) infiltration, intra-islet infiltration, and extensive intra-islet infiltration covering the entire islet. For immunohistochemical staining, tissues were fixed in Bouin's solution, processed, and paraffin-embedded.…”
Section: Histologymentioning
confidence: 99%
“…In these mice, a diminished insulin secretion is present 15 days after the transfer procedure, and a preferential trapping of transferred diab.MS in islets of recipient mice was observed. Diab.MS obtained as early as day 4, were able to impair insulin secretion in transferred normal syngeneic recipients (Buschard et al, 1977;Pastorale et al, 2002;Karabatas et al, 2000 and.…”
mentioning
confidence: 99%